langka

The Canadian Cholangiocarcinoma Collaborative (C3) is a grant-funded group of clinicians, researchers, and scientists across Canada that are working together to research new cures and clinical trials for patients with Bile Tract Cancer. We want to inspire Hope through research and education. We are also going to be running a clinical trial that uses cutting edge adoptive T cell therapy known as Tumour Infiltrating Lymphocyte therapy. Cholangiocarcinoma is an aggressive cancer that has low survival rates, and the C3 is here to increase access to research opportunities.